In solid tumors such as melanoma and hepatocellular carcinoma (HCC), SHP2 activity positively correlates with PD-L1 expression, further underscoring its central role in modulating the tumor immune microenvironment [23,24]. This evidence concerns the gene CD274 and hepatocellular carcinoma.